📰 Exon Skipping News
Exon Skipping News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exon Skipping. Real-time updates on events, politics, business and more.
May 23, 2024
Nucleic acids in blood can provide valuable information about cancer, but how can we stabilize them prior to analysis?
April 23, 2024
Nucleic acids in blood can provide valuable information about cancer, but how can we stabilize them prior to analysis?
April 22, 2024
Nucleic acids in blood can provide valuable information about cancer, but how can we stabilize them prior to analysis?
February 27, 2024
Presentations include data for WVE-N531 that provide first clinical evidence of a potential therapeutic for DMD accessing satellite cells, which are important for potential muscle regeneration ...
October 24, 2023
/PRNewswire/ -- The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. The...
October 9, 2023
Sarah Boyce, president and CEO at Avidity Biosciences, discusses her leading role at the company, as well as antibody oligonucleotide conjugate drug, AOC 1044, currently in development for Duchenne muscular dystrophy (DMD) with mutations amenable to exon 44 skipping (DMD44).
September 27, 2023
BOSTON, Sept. 27, 2023 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe...
April 10, 2023
According to Coherent Market Insights, Global Cancer supportive care products Market is estimated to be valued at US$ 32,458.0 million in 2023 and is expected
October 5, 2021
The Oligonucleotide Synthesis Market To Move Along The Growing Radius Of Curvature (US$ 540 Million) From 2025